Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) and Health In Tech (NASDAQ:HIT – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.
Valuation & Earnings
This table compares Firefly Neuroscience and Health In Tech”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Firefly Neuroscience | $1.14 million | 14.59 | -$19.88 million | ($0.59) | -1.80 |
| Health In Tech | $32.83 million | 1.13 | -$4.59 million | ($0.07) | -8.06 |
Health In Tech has higher revenue and earnings than Firefly Neuroscience. Health In Tech is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Firefly Neuroscience and Health In Tech, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Firefly Neuroscience | 1 | 0 | 0 | 0 | 1.00 |
| Health In Tech | 1 | 0 | 1 | 1 | 2.67 |
Health In Tech has a consensus price target of $3.50, suggesting a potential upside of 520.35%. Given Health In Tech’s stronger consensus rating and higher probable upside, analysts plainly believe Health In Tech is more favorable than Firefly Neuroscience.
Institutional and Insider Ownership
5.0% of Firefly Neuroscience shares are owned by institutional investors. 6.9% of Firefly Neuroscience shares are owned by company insiders. Comparatively, 77.7% of Health In Tech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Volatility & Risk
Firefly Neuroscience has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Comparatively, Health In Tech has a beta of 2.81, meaning that its stock price is 181% more volatile than the S&P 500.
Profitability
This table compares Firefly Neuroscience and Health In Tech’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Firefly Neuroscience | -506.23% | -90.17% | -72.05% |
| Health In Tech | N/A | N/A | N/A |
Summary
Health In Tech beats Firefly Neuroscience on 12 of the 15 factors compared between the two stocks.
About Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
About Health In Tech
Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
Receive News & Ratings for Firefly Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Firefly Neuroscience and related companies with MarketBeat.com's FREE daily email newsletter.
